More Articles Back to Article
Japan's Moderna approval still months away, officials say
A trial of Moderna's COVID-19 vaccine will likely take several months and regulatory approval will not likely happen until May, said Masayuki Imagawa, head of the Japan vaccine business for Takeda Pharmaceutical Co., which is working with Japanese officials on the Moderna vaccine. Approval for a vaccine by Novavax is further away, and the lack of vaccine approval may affect the Tokyo Olympics. Reuters (1/7)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!